A Novel Sulindac Derivative Protects against Oxidative Damage by a Cyclooxygenase-Independent Mechanism Article

Allani, Shailaja Kesaraju, Rayala, Ramanjaneyulu, Rivera, Oscar et al. (2022). A Novel Sulindac Derivative Protects against Oxidative Damage by a Cyclooxygenase-Independent Mechanism . JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 382(2), 79-87. 10.1124/jpet.122.001086

Open Access

cited authors

  • Allani, Shailaja Kesaraju; Rayala, Ramanjaneyulu; Rivera, Oscar; Prentice, Howard M; Chen, Xi; Ramirez-Alcantara, Veronica; Canzoneri, Joshua; Menzie-Suderam, Janet; Huang, Xupei; Georgescu, Constantin; Wren, Jonathan D; Piazza, Gary A; Weissbach, Herbert

sustainable development goals

publication date

  • August 1, 2022

keywords

  • ACTIVATION
  • APOPTOSIS
  • CARDIOPROTECTION
  • HEART
  • INHIBITION
  • ISCHEMIA
  • Life Sciences & Biomedicine
  • PHOSPHODIESTERASE
  • Pharmacology & Pharmacy
  • REDUCTION
  • SULFIDE
  • Science & Technology
  • TUMOR CELL-GROWTH

Digital Object Identifier (DOI)

publisher

  • AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS

start page

  • 79

end page

  • 87

volume

  • 382

issue

  • 2